Toll-Like Receptor Activation in Immunity Vs. Tolerance in Autoimmune Diabetes

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2014 Apr 10

PMID 24715890

Citations 11

Authors

Elke Gulden

Li Wen

Affiliations

Soon will be listed here.

Citing Articles

PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy.

Koerner J, Horvath D, Herrmann V, MacKerracher A, Gander B, Yagita H Nat Commun. 2021; 12(1):2935.

PMID: 34006895 PMC: 8131648. DOI: 10.1038/s41467-021-23244-3.

Fatty acid binding protein 4 promotes autoimmune diabetes by recruitment and activation of pancreatic islet macrophages.

Xiao Y, Shu L, Wu X, Liu Y, Cheong L, Liao B JCI Insight. 2021; 6(7).

PMID: 33690220 PMC: 8119222. DOI: 10.1172/jci.insight.141814.

Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?).

Roep B, Thomaidou S, van Tienhoven R, Zaldumbide A Nat Rev Endocrinol. 2020; 17(3):150-161.

PMID: 33293704 PMC: 7722981. DOI: 10.1038/s41574-020-00443-4.

Phagocyte Transcriptomic Analysis Reveals Focal Adhesion Kinase (FAK) and Heparan Sulfate Proteoglycans (HSPGs) as Major Regulators in Anti-bacterial Defense of .

Lin Y, Mao F, Wong N, Zhang X, Liu K, Huang M Front Immunol. 2020; 11:416.

PMID: 32265912 PMC: 7103635. DOI: 10.3389/fimmu.2020.00416.

Dietary Iron and Heme Iron Consumption, Genetic Susceptibility, and Risk of Crohn's Disease and Ulcerative Colitis.

Khalili H, de Silva P, Ananthakrishnan A, Lochhead P, Joshi A, Garber J Inflamm Bowel Dis. 2017; 23(7):1088-1095.

PMID: 28604414 PMC: 5549140. DOI: 10.1097/MIB.0000000000001161.

References

Zanin-Zhorov A, Cohen I . Signaling via TLR2 and TLR4 Directly Down-Regulates T Cell Effector Functions: The Regulatory Face of Danger Signals. Front Immunol. 2013; 4:211. PMC: 3722573. DOI: 10.3389/fimmu.2013.00211. View

Lee A, Ghoreishi M, Cheng W, Chang T, Zhang Y, Dutz J . Toll-like receptor 7 stimulation promotes autoimmune diabetes in the NOD mouse. Diabetologia. 2011; 54(6):1407-16. DOI: 10.1007/s00125-011-2083-y. View

Akira S, Takeda K, Kaisho T . Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001; 2(8):675-80. DOI: 10.1038/90609. View

Liu H, Komai-Koma M, Xu D, Liew F . Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells. Proc Natl Acad Sci U S A. 2006; 103(18):7048-53. PMC: 1444884. DOI: 10.1073/pnas.0601554103. View

Lang K, Recher M, Junt T, Navarini A, Harris N, Freigang S . Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat Med. 2005; 11(2):138-45. DOI: 10.1038/nm1176. View

Tai N, Wong F, Wen L . TLR9 deficiency promotes CD73 expression in T cells and diabetes protection in nonobese diabetic mice. J Immunol. 2013; 191(6):2926-37. PMC: 3788667. DOI: 10.4049/jimmunol.1300547. View

Fallarino F, Volpi C, Zelante T, Vacca C, Calvitti M, Fioretti M . IDO mediates TLR9-driven protection from experimental autoimmune diabetes. J Immunol. 2009; 183(10):6303-12. DOI: 10.4049/jimmunol.0901577. View

Bach J, Chatenoud L . The hygiene hypothesis: an explanation for the increased frequency of insulin-dependent diabetes. Cold Spring Harb Perspect Med. 2012; 2(2):a007799. PMC: 3281594. DOI: 10.1101/cshperspect.a007799. View

Zipris D, Lien E, Nair A, Xie J, Greiner D, Mordes J . TLR9-signaling pathways are involved in Kilham rat virus-induced autoimmune diabetes in the biobreeding diabetes-resistant rat. J Immunol. 2007; 178(2):693-701. DOI: 10.4049/jimmunol.178.2.693. View

10.

Moriyama H, Wen L, Abiru N, Liu E, Yu L, Miao D . Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide. Proc Natl Acad Sci U S A. 2002; 99(8):5539-44. PMC: 122805. DOI: 10.1073/pnas.082120099. View

11.

Fischer M, Ehlers M . Toll-like receptors in autoimmunity. Ann N Y Acad Sci. 2008; 1143:21-34. DOI: 10.1196/annals.1443.012. View

12.

Kim H, Han M, Chung K, Kim S, Kim E, Kim M . Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes. Immunity. 2007; 27(2):321-33. DOI: 10.1016/j.immuni.2007.06.010. View

13.

Aumeunier A, Grela F, Ramadan A, Pham Van L, Bardel E, Gomez Alcala A . Systemic Toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice. PLoS One. 2010; 5(7):e11484. PMC: 2900205. DOI: 10.1371/journal.pone.0011484. View

14.

Sutmuller R, Garritsen A, Adema G . Regulatory T cells and toll-like receptors: regulating the regulators. Ann Rheum Dis. 2007; 66 Suppl 3:iii91-5. PMC: 2095279. DOI: 10.1136/ard.2007.078535. View

15.

Ding Y, Subramanian S, Montes V, Goodspeed L, Wang S, Han C . Toll-like receptor 4 deficiency decreases atherosclerosis but does not protect against inflammation in obese low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol. 2012; 32(7):1596-604. PMC: 3748807. DOI: 10.1161/ATVBAHA.112.249847. View

16.

Trudeau J, Dutz J, Arany E, Hill D, Fieldus W, Finegood D . Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes?. Diabetes. 2000; 49(1):1-7. DOI: 10.2337/diabetes.49.1.1. View

17.

Schulthess F, Paroni F, Sauter N, Shu L, Ribaux P, Haataja L . CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling. Cell Metab. 2009; 9(2):125-39. DOI: 10.1016/j.cmet.2009.01.003. View

18.

Wong F, Hu C, Zhang L, Du W, Alexopoulou L, Flavell R . The role of Toll-like receptors 3 and 9 in the development of autoimmune diabetes in NOD mice. Ann N Y Acad Sci. 2009; 1150:146-8. DOI: 10.1196/annals.1447.039. View

19.

Chen Q, Davidson T, Huter E, Shevach E . Engagement of TLR2 does not reverse the suppressor function of mouse regulatory T cells, but promotes their survival. J Immunol. 2009; 183(7):4458-66. PMC: 2788511. DOI: 10.4049/jimmunol.0901465. View

20.

Crellin N, Garcia R, Hadisfar O, Allan S, Steiner T, Levings M . Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells. J Immunol. 2005; 175(12):8051-9. DOI: 10.4049/jimmunol.175.12.8051. View